AI Copilot

Clinical Copilot

Real-time AI assistant that watches your consultation notes and surfaces contextual suggestions

45y / Male|Type 2 DiabetesHypertension|Allergy: Sulfa drugs|Risk: 72/100
Consultation Notes
Current Medications
Metformin 1000mg BDGlimepiride 2mg ODLosartan 50mg OD

Prescribe Medication

AI Copilot
Live
guideline

ADA 2026 Guidelines

For HbA1c >8% on dual therapy, consider adding GLP-1 RA (e.g., Semaglutide) or SGLT2i (e.g., Empagliflozin) — especially with concurrent CKD or CVD risk.

ADA Standards of Medical Care 2026, Section 9

risk

Diabetic Nephropathy Risk

Microalbumin/Cr ratio 45 mg/g (elevated). Early diabetic nephropathy suspected. SGLT2 inhibitors have proven renal protective benefits.

CREDENCE Trial, DAPA-CKD Trial

follow-up

Retinopathy Screening Due

Patient has not had dilated eye exam in 14 months. Annual screening recommended for all diabetic patients.

ADA Guidelines 2026

order

Suggested Lab Orders

Based on current clinical picture: HbA1c (3-month recheck), Lipid panel, Renal function panel (eGFR + uACR), Hepatic function.

Quick Actions

Clinical Risk Scores
72/100
Cardiovascular risk
HIGH
Renal risk
MODERATE
Overall trend
Needs attention